Cart
sales@molnova.com
Yinxiancaoside C
CAS No. 1159908-74-3
Yinxiancaoside C( —— )
Catalog No. M32323 CAS No. 1159908-74-3
Yinxiancaoside C has antitumor effect.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 691 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameYinxiancaoside C
-
NoteResearch use only, not for human use.
-
Brief DescriptionYinxiancaoside C has antitumor effect.
-
DescriptionYinxiancaoside C has antitumor effect.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1159908-74-3
-
Formula Weight578.5
-
Molecular FormulaC27H30O14
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Arch Pharm Res . 2009 Mar;32(3):329-334.
molnova catalog
related products
-
Kira8
Kira8 is a mono-selective IRE1α inhibitor that allosterically attenuates IRE1α RNase activity (IC50: 5.9 nM).
-
Nucleoprotein 118-12...
Nucleoprotein (118-126),a fragment of Nucleoprotein, is a 9-aa peptide .
-
(Z)-PUGNAc
(Z)-PUGNAc, a potent O-GlcNAcase inhibitor more active than (E)-PUGNAc, removes O-GlcNAc from proteins (peptide O-GlcNAc-β-N-acetylaminoglucosidase) and can be used to increase levels of O-GlcNAc on nuclear and cytoplasmic proteins in vivo.
